Faculty Publications
Department of Internal Medicine faculty publish in a wide variety of journals and on topics pertaining to all our divisions. Faculty members, house officers, postdoctoral fellows, students, and staff members support the research mission of the department. The Internal Medicine Research Council provides research advocacy and training. Please email if you have questions.
Internal Medicine Publications of the Quarter
At the conclusion of each quarter of the year, an Internal Medicine faculty publication is recognized for its outstanding quality of research and scientific impact, known as the Publication of the Quarter. The following authors have been reccognized with this award for their outstanding publications:
Quarter Two, 2024
Helget LN, Davis-Karim A, O'Dell JR, Mikuls TR, Newcomb JA, Androsenko M, Brophy MT, England BR, Ferguson R, Pillinger MH, Neogi T, Wu H, Palevsky PM. Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial. Am J Kidney Dis. 2024 Nov;84(5):538-545. doi: 10.1053/j.ajkd.2024.04.017. Epub 2024 Jun 19. PMID: 38906504.
Honorable mention:
Kesireddy M, Elsayed L, Shostrom VK, Agarwal P, Asif S, Yellala A, Krishnamurthy J. Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis. Cancers (Basel). 2024 May 8;16(10):1791. doi: 10.3390/cancers16101791. PMID: 38791870; PMCID: PMC11120599.
Quarter One, 2024
Bares SH, Wu X, Tassiopoulos K, Lake JE, Koletar SL, Kalayjian R, Erlandson KM. Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease. Clin Infect Dis. 2024 Feb 17;78(2):395-401. doi: 10.1093/cid/ciad545. PMID: 37698083; PMCID: PMC10874261.
Honorable mention:
Krutsinger DC, Maloney SI, Courtright KR, Bartels K. Barriers and Facilitators of Surrogates Providing Consent for Critically Ill Patients in Clinical Trials: A Qualitative Study. Chest. 2024 Feb 20:S0012-3692(24)00262-9. doi: 10.1016/j.chest.2024.02.027. Epub ahead of print. PMID: 38387647.
Quarter Four, 2023
Shi W, Mirza S, Kuss M, Liu B, Hartin A, Wan S, Kong Y, Mohapatra B, Krishnan M, Band H, Band V, Duan B. Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low-Concentration Collagen-Based Bioinks. Adv Healthc Mater. 2023 Oct;12(26):e2300905. doi: 10.1002/adhm.202300905. Epub 2023 Jul 14. PMID: 37422447; PMCID: PMC10592394.
Honorable mention:
Wiedel NA, Sayles H, Larson J, Wardian JL, Hewlett A, McClay J, Ge J, Anzalone AJ; N3C consortium. Associations between COVID-19 therapies and inpatient gastrointestinal bleeding: A multisite retrospective study. J Med Virol. 2023 Oct;95(10):e29100. doi: 10.1002/jmv.29100. PMID: 37786247.
Quarter Three, 2023
Johnson TM, Mahabir CA, Yang Y, Roul P, Goldsweig AM, Binstadt BA, Baker JF, Sauer BC, Cannon GW, Mikuls TR, England BR. Aortic Stenosis Risk in Rheumatoid Arthritis. JAMA Intern Med. 2023 Jul 31;183(9):973–81. doi: 10.1001/jamainternmed.2023.3087. Epub ahead of print. PMID: 37523173; PMCID: PMC10391353.
Honorable mention:
Stuver R, Horwitz SM, Advani RH, Vose JM, Lee HJ, Mehta-Shah N, Zain JM, Haverkos B, Lechowicz MJ, Moskowitz AJ, Pham LQ, Leyden E, Ansell SM, Lunning MA. Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. Br J Haematol. 2023 Aug;202(3):525-529. doi: 10.1111/bjh.18885. Epub 2023 May 22. PMID: 37217196.
Quarter Two, 2023
El-Kersh K, Zhao C, Elliott G, Farber HW, Gomberg-Maitland M, Selej M, Garcia-Ferrer J, Benza R. Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension. Chest. 2023 May;163(5):1232-1244. doi: 10.1016/j.chest.2022.12.045. Epub 2023 Jan 9. PMID: 36634897; PMCID: PMC10268808.
Quarter One, 2023
Johnson J, Goldner W, Abdallah D, Qiu F, Ganti AK, Kotwal A. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival. J Natl Compr Canc Netw. 2023 Feb 24;21(3):281-287. doi: 10.6004/jnccn.2022.7098. PMID: 36828029.
Honorable Mention:
England BR, Yang Y, Roul P, Haas C, Najjar L, Sayles H, Yu F, Sauer BC, Baker JF, Xie F, Michaud K, Curtis JR, Mikuls TR. Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning. Arthritis Care Res (Hoboken). 2023 Feb;75(2):220-230. doi: 10.1002/acr.24956. Epub 2022 Oct 19. PMID: 35588095; PMCID: PMC10009900.
Quarter Four, 2022
Morgan NN, Duck LW, Wu J, Rujani M, Thomes PG, Elson CO, Mannon PJ. Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset. Inflamm Bowel Dis. 2022 Dec 1;28(12):1893-1903. doi: 10.1093/ibd/izac146. PMID: 35931421.
Quarter Three, 2022
Bhatt VR, Wichman C, Al-Kadhimi ZS, Koll TT, Fisher AL, Mahato RI, Hyde RK, Berger A, Armitage JO, Holstein SA, Maness LJ, Gundabolu K. Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia. J Geriatr Oncol. 2022 Jul;13(6):871-874. doi: 10.1016/j.jgo.2022.04.005. Epub 2022 Apr 18. PMID: 35450817; PMCID: PMC9482687.
Quarter Two, 2022
Min Gu, Derrick R. Samuelson, de la Rua NM, Charles TP, Taylor CM, Luo M, Siggins RW, Shellito JE, Welsh DA. Host innate and adaptive immunity shapes the gut microbiota biogeography. Microbiol Immunol. 2022 Jun;66(6):330-341. doi: 10.1111/1348-0421.12963. Epub 2022 May 26. PMID: 35067963; PMCID: PMC9189012.
Quarter One, 2022
James R. O’Dell, Brophy MT, Pillinger MH, Neogi T, Palevsky PM, Wu H, Davis-Karim A, Newcomb JA, Ferguson R, Pittman D, Cannon GW, Taylor T, Terkeltaub R, Cannella AC, England BR, Helget LN, Mikuls TR. Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management. NEJM Evid. 2022 Mar;1(3):10.1056/evidoa2100028. doi: 10.1056/evidoa2100028. Epub 2022 Feb 3. PMID: 35434725; PMCID: PMC9012032.